Sonavex
Baltimore
About Sonavex
Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $33.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: sonavex.com
- Phone: (443) 797-2584
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/sonavex-85815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.